Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission-Reference-Cited by-同舟云学术

Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission

Published:2019-10 Issue: Volume:216 Page:143-146
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Vroegindewey Maxime M.,van den Berg Victor J.,Bouwens Elke,Akkerhuis K. Martijn,Oemrawsingh Rohit M.,Asselbergs Folkert W,Lenderink Timo,van der Harst Pim,Ronner Eelco,Umans Victor A.W.M.,Kardys Isabella,Boersma Eric

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Galectin-3 in acute coronary syndrome;Agnello;Clin Biochem,2017

2. Myeloperoxidase and cardiovascular disease;Nicholls;Arterioscler Thromb Vasc Biol,2005

3. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes;Baldus;Circulation,2003

4. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome;Cavusoglu;Am J Cardiol,2007

5. Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands;Oemrawsingh;BMJ Open,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress Biomarkers in Coronary Artery Disease;Current Topics in Medicinal Chemistry;2023-09

2. Research progress on the role of gal-3 in cardio/cerebrovascular diseases;Biomedicine & Pharmacotherapy;2021-01

3. Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS;Data in Brief;2019-12